| 注册
首页|期刊导航|中国药物经济学|前列地尔联合替米沙坦治疗早期糖尿病肾病的临床疗效

前列地尔联合替米沙坦治疗早期糖尿病肾病的临床疗效

于春梅

中国药物经济学Issue(3):54-56,3.
中国药物经济学Issue(3):54-56,3.

前列地尔联合替米沙坦治疗早期糖尿病肾病的临床疗效

The Clinical Curative Effect of Treating Early Diabetic Nephropathy with Alprostadil Combined with Telmisartan

于春梅1

作者信息

  • 1. 阜新市糖尿病医院内分泌科,辽宁阜新 123000
  • 折叠

摘要

Abstract

Objective To investigate the clinical curative effect of alprostadil combined with telmisartan in treating early diabetic nephropathy.Methods From 2014 January to 2015 January in our hospital treatment of 86 cases of early diabetic nephropathy patients,the use of a double blind randomized grouping,43 patients in the control group given telmisartan treatment,the observation group of 43 patients in the control group based on the application of alprostadil treatment,compared two groups of biochemical indexes.Results The biochemical indexes were compared between the two groups before treatment,no significant difference(P>0.05);after the treatment,the observation group of patients with urinary albumin,24 h urinary protein,blood urea nitrogen,blood creatinine levels decreased significantly better than the control group,the difference was statistical y significant(P<0.05).Conclusion Effect of alprostadil combined with telmisartan in treating early diabetic nephropathyis more prominent,the clinical effect of higher value.

关键词

前列地尔/替米沙坦/糖尿病肾病

Key words

Alprostadil/Ti Mi Chatain/Diabetic nephropathy

分类

医药卫生

引用本文复制引用

于春梅..前列地尔联合替米沙坦治疗早期糖尿病肾病的临床疗效[J].中国药物经济学,2015,(3):54-56,3.

中国药物经济学

1673-5846

访问量0
|
下载量0
段落导航相关论文